Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP610253.RAXj3F-XD1Etds5W2oCxCFyOabVb14JjKYjPlrWyEbvN8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP610253.RAXj3F-XD1Etds5W2oCxCFyOabVb14JjKYjPlrWyEbvN8130_assertion type Assertion NP610253.RAXj3F-XD1Etds5W2oCxCFyOabVb14JjKYjPlrWyEbvN8130_head.
- NP610253.RAXj3F-XD1Etds5W2oCxCFyOabVb14JjKYjPlrWyEbvN8130_assertion description "[To determine the prevalence and prognostic impact of significant acute lymphoblastic leukemia (ALL) -related genes: CRLF2 deregulation (CRLF2-d), IGH@ translocations (IGH@-t), and deletions of CDKN2A/B, IKZF1, PAX5, ETV6, RB1, BTG1, and EBF1 in adolescents and adults.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP610253.RAXj3F-XD1Etds5W2oCxCFyOabVb14JjKYjPlrWyEbvN8130_provenance.
- NP610253.RAXj3F-XD1Etds5W2oCxCFyOabVb14JjKYjPlrWyEbvN8130_assertion evidence source_evidence_literature NP610253.RAXj3F-XD1Etds5W2oCxCFyOabVb14JjKYjPlrWyEbvN8130_provenance.
- NP610253.RAXj3F-XD1Etds5W2oCxCFyOabVb14JjKYjPlrWyEbvN8130_assertion SIO_000772 22851563 NP610253.RAXj3F-XD1Etds5W2oCxCFyOabVb14JjKYjPlrWyEbvN8130_provenance.
- NP610253.RAXj3F-XD1Etds5W2oCxCFyOabVb14JjKYjPlrWyEbvN8130_assertion wasDerivedFrom befree-20150227 NP610253.RAXj3F-XD1Etds5W2oCxCFyOabVb14JjKYjPlrWyEbvN8130_provenance.
- NP610253.RAXj3F-XD1Etds5W2oCxCFyOabVb14JjKYjPlrWyEbvN8130_assertion wasGeneratedBy ECO_0000203 NP610253.RAXj3F-XD1Etds5W2oCxCFyOabVb14JjKYjPlrWyEbvN8130_provenance.